Triple-negative breast cancer (TNBC) is a subclass of breast tumors that lack estrogen receptor (ER) and progesterone receptor (PgR) expression, as determined by immunohistochemistry (IHC). This evidence concerns the gene ESR1 and breast neoplasm.